Table 5.
Oxylipins | v (Total) | v (Esterified) | v (Free) | F (Total) | F (Esterified) | F (Free) |
---|---|---|---|---|---|---|
9-HODE | 0.13 ± 0.054 | 0.13 ± 0.05 | 0.0001 ± 0.0001* | 9.12 ± 3.48 | 9.17 ± 3.49 | 0.85 ± 1.24* |
13-HODE | 0.25 ± 0.13 | 0.25 ± 0.13 | 0.0006 ± 0.0005* | 17.53 ± 9.22 | 17.60 ± 9.25 | 6.37 ± 4.69 |
9-oxo-ODE | 0.052 ± 0.028 | 0.052 ± 0.028 | 0.0001 ± 0.0001* | 3.63 ± 1.93 | 3.64 ± 1.94 | 1.33 ± 1.14 |
13-oxo-ODE | 0.032 ± 0.019 | 0.032 ± 0.019 | NQ 1 | 2.25 ± 1.29 | 2.27 ± 1.30 | NQ |
9(10)-EpOME | 0.040 ± 0.082 | 0.039 ± 0.082 | 0.0002 ± 0.0002 | 2.69 ± 5.45 | 2.70 ± 5.49 | 2.18 ± 1.56 |
12(13)-EpOME | 0.097 ± 0.14 | 0.095 ± 0.14 | 0.0014 ± 0.0005 | 6.61 ± 9.53 | 6.56 ± 9.62 | 13.74 ± 4.74 |
9,10-DiHOME | −0.0002 ± 0.014 | −0.0002 ± 0.014 | −0.0001 ± 0.0001 | −0.0002 ± 0.0094 | −0.0001 ± 0.0095 | −0.0065 ± 0.0091 |
12,13-DiHOME | 0.0056 ± 0.0069 | 0.0056 ± 0.0069 | −0.0001 ± 0.0001 | 0.39 ± 0.49 | 0.40 ± 0.49 | −0.0058 ± 0.0082 |
9,10,13-TriHOME | NQ | NQ | −0.00002 ± 0.00002 | NQ | NQ | −0.0017 ± 0.0024 |
9,12,13-TriHOME | NQ | NQ | NQ | NQ | NQ | NQ |
ΣLA-derived oxylipins | 0.61 ± 0.20 | 0.61 ± 0.20 | 0.0023 ± 0.0015* | 42.20 ± 12.38 | 42.33 ± 12.47 | 23.31 ± 14.74 |
9-HOTrE | 0.012 ± 0.0067 | 0.012 ± 0.0067 | NQ | 6.65 ± 3.62 | 6.70 ± 3.63 | NQ |
13-HOTrE | 0.027 ± 0.018 | 0.027 ± 0.018 | NQ | 15.01 ± 9.85 | 15.12 ± 9.90 | NQ |
ΣALA-derived oxylipins | 0.038 ± 0.025 | 0.038 ± 0.025 | NQ | 21.65 ± 13.45 | 21.81 ± 13.51 | NQ |
Velocity and turnover data are expressed at mean ± SD of n = 5 per oxylipin within each lipid fraction (total, esterified and free).
1NQ: not quantified because the PGE2 surrogate standard used to quantify the analyte degraded during hydrolysis (for esterified TriHOMEs), or a slope was not determined from the Concentration-Time plot due to non-detected values over time (free 13-oxo-ODE, 9,12,13-TriHOME, 9-HOTrE, and 13-HOTrE).
*Velocity or turnover of esterified oxylipin is significantly different from that of free oxylipin (p < 0.05) by unpaired t-test.